Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Angiotensin II Signaling

  • Masaaki Tamura
  • Takaya Matsuzuka
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_282-2



The angiotensin peptides (angiotensins I, II, III, IV, and -(1–7)) are derived from the precursor angiotensinogen by sequential processing proteases such as renin, angiotensin I-converting enzyme (ACE), chymase, and other peptidases. Among these peptides, angiotensin II has been well studied and is shown to be the most biologically active peptide. This peptide hormone production system is called the renin-angiotensin system and is one of the phylogenetically oldest hormone systems that has been conserved throughout evolution. The renin-angiotensin system plays a key role in the maintenance of arterial blood pressure and fluid and electrolyte homeostasis. There are two well-defined receptors of angiotensin II (subtype 1 (AT1) and subtype 2 (AT2)), both of which have seven transmembrane, G-protein coupled receptors and are encoded by different genes (AT1 (agtr1), 3q21–25; AT2 (agtr2), Xq22–23). The major isoform, AT1receptor, is expressed in a wide...


Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Transactivation Ovarian Cancer Malignancy Peptide Hormone Production Positive Ovarian Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Berry C, Touyz R, Dominiczak AF et al (2001) Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281:H2337–H2365PubMedGoogle Scholar
  2. Egami K, Murohara T, Shimada T et al (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112:67–75CrossRefPubMedPubMedCentralGoogle Scholar
  3. Ino K, Shibata K, Kajiyama H et al (2006) Manipulating the angiotensin system – new approaches to the treatment of solid tumours. Expert Opin Biol Ther 6:243–255CrossRefPubMedGoogle Scholar
  4. Kanehira T, Tani T, Takagi T et al (2005) Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation. Cancer Res 65:7660–7665PubMedGoogle Scholar
  5. Lever AF, Hole DJ, Gillis CR et al (1998) Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352:179–184CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of Anatomy and PhysiologyKansas State UniversityManhattanUSA